154 related articles for article (PubMed ID: 12131903)
1. Another FDA warning: Kava supplements.
Parkman CA
Case Manager; 2002; 13(4):26-8. PubMed ID: 12131903
[No Abstract] [Full Text] [Related]
2. Risk of kava hepatotoxicity and the FDA consumer advisory.
Teschke R; Schulze J
JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
[No Abstract] [Full Text] [Related]
3. Kava concerns. FDA, Botanical Council raises safety concerns.
AWHONN Lifelines; 2002; 6(1):13-5. PubMed ID: 11971236
[No Abstract] [Full Text] [Related]
4. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(47):1065-7. PubMed ID: 12500906
[TBL] [Abstract][Full Text] [Related]
5. Kava hepatotoxicity solution: A six-point plan for new kava standardization.
Teschke R; Sarris J; Lebot V
Phytomedicine; 2011 Jan; 18(2-3):96-103. PubMed ID: 21112196
[TBL] [Abstract][Full Text] [Related]
6. From the Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
JAMA; 2003 Jan; 289(1):36-7. PubMed ID: 12515265
[No Abstract] [Full Text] [Related]
7. Kava: a supplement to avoid.
Consum Rep; 2003 Mar; 68(3):8. PubMed ID: 12599340
[No Abstract] [Full Text] [Related]
8. Are dietary supplements safe?
Kam RY
HDA Now; 2013; ():18-9. PubMed ID: 24427969
[No Abstract] [Full Text] [Related]
9. Problems with dietary supplements.
Med Lett Drugs Ther; 2002 Sep; 44(1140):84-6. PubMed ID: 12360122
[No Abstract] [Full Text] [Related]
10. A re-evaluation of kava (Piper methysticum).
Ernst E
Br J Clin Pharmacol; 2007 Oct; 64(4):415-7. PubMed ID: 17555466
[No Abstract] [Full Text] [Related]
11. [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?].
Teschke R
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1880-1; author reply 1882-3. PubMed ID: 16915552
[No Abstract] [Full Text] [Related]
12. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
Teschke R; Genthner A; Wolff A
J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
[TBL] [Abstract][Full Text] [Related]
13. The curious case of Kava.
Grossman L
Time; 2002 Apr; 159(14):58. PubMed ID: 11951318
[No Abstract] [Full Text] [Related]
14. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia.
Russmann S; Barguil Y; Cabalion P; Kritsanida M; Duhet D; Lauterburg BH
Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1033-6. PubMed ID: 12923378
[TBL] [Abstract][Full Text] [Related]
15. Relevant hepatotoxic effects of kava still need to be proven. A statement of the Society for Medicinal Plant Research.
Society for Medicinal Plant Research
Planta Med; 2003 Nov; 69(11):971-2. PubMed ID: 14735431
[No Abstract] [Full Text] [Related]
16. Adverse reactions to dietary supplements under investigation by FDA.
Marwick C
BMJ; 2002 Aug; 325(7359):298. PubMed ID: 12173613
[No Abstract] [Full Text] [Related]
17. Kava hepatotoxicity: a European view.
Teschke R; Schwarzenboeck A; Akinci A
N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189
[TBL] [Abstract][Full Text] [Related]
18. Natural-born killers.
Mandavilli A
Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
[No Abstract] [Full Text] [Related]
19. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory.
Schmidt M
J Altern Complement Med; 2003 Apr; 9(2):183-7; author reply 187-8. PubMed ID: 12804070
[No Abstract] [Full Text] [Related]
20. Risky pills: supplements to avoid.
Consum Rep; 2008 Jan; 73(1):46-7. PubMed ID: 18488285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
